pith. sign in

arxiv: 2604.07738 · v1 · submitted 2026-04-09 · 🧮 math.OC

Optimizing Treatment Allocation to Maximize the Health of a Population

Daniel Adelman , Alba V Olivares-Nadal , Miaolan Xie This is my paper

Pith reviewed 2026-05-10 18:09 UTC · model grok-4.3

classification 🧮 math.OC
keywords population health managementmeasurized MDPindex policyadjusted impactabilitytreatment allocationapproximate dynamic programmingnon-maleficence constraintCMS data
0
0 comments X

The pith

A threshold on adjusted impactability selects patients for scarce treatments to maximize long-term population health.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper proposes using measurized Markov decision processes to optimize the allocation of scarce treatments across a healthcare population for improved long-term health outcomes. This approach matters as it sidesteps the difficulty of managing evolving high-dimensional patient data by focusing on population-level distributions instead. It produces an easy-to-use index rule that treats patients when their adjusted impactability, reflecting long-term effects, crosses a threshold, while enforcing ethical mortality limits. Data from CMS shows this policy significantly outperforms myopic selection, with the benefit growing for longer planning periods and yielding over 1,500 more home days per year for each thousand patients.

Core claim

By modeling the healthcare population as a measure in an MDP that optimizes its long-term distribution under capacity constraints and a non-maleficence limit on mortality, the approach reduces the problem to selecting a finite set of high-performing patients. Approximate dynamic programming then yields an index policy where treatment is given if adjusted impactability, which incorporates long-term effects, exceeds a threshold. This policy is clinically implementable and flexible with machine learning models. On CMS data, it produces statistically significant improvements over myopic benchmarks that increase with the planning horizon, equating to over 1,500 additional home days per year for 1

What carries the argument

The measurized MDP on population measures, which bypasses high-dimensional individual covariates by working with distributions, and the resulting adjusted impactability index that encodes the value of treating or not treating a patient type in the long run.

If this is right

  • Patients can be ranked and selected using a threshold on their adjusted impactability score, making the policy easy to apply in practice.
  • The performance advantage over myopic policies grows as the time horizon lengthens, aligning with the forward-looking optimization.
  • The non-maleficence constraint keeps mortality rates within ethical bounds during optimization.
  • The method accommodates general machine learning models for estimating impactability while remaining computationally tractable.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • Similar index policies could apply to allocating other limited medical resources like ICU beds or specialist referrals by adapting the population measure.
  • Testing the policy in prospective clinical trials would verify real-world gains beyond retrospective CMS data analysis.
  • Integrating patient inflow and outflow more dynamically might further enhance the model's accuracy for open populations.

Load-bearing premise

The population health dynamics and long-term treatment responses can be adequately captured by a measurized MDP that bypasses explicit tracking of high-dimensional individual patient covariates, while the non-maleficence constraint sufficiently ensures ethical compliance.

What would settle it

Observing no statistically significant increase in home days or similar metrics when the index policy is applied versus a myopic benchmark on held-out CMS data or a prospective cohort over multi-year horizons would falsify the performance claim.

Figures

Figures reproduced from arXiv: 2604.07738 by Alba V Olivares-Nadal, Daniel Adelman, Miaolan Xie.

Figure 1
Figure 1. Figure 1: Flowchart illustrating the population dynamics in the Measurized MDP for treatment [PITH_FULL_IMAGE:figures/full_fig_p013_1.png] view at source ↗
Figure 2
Figure 2. Figure 2: Annualized improvement in home days per 1,000 patients (ADP minus myopic) as a [PITH_FULL_IMAGE:figures/full_fig_p026_2.png] view at source ↗
Figure 3
Figure 3. Figure 3: Uniform and Normal distributions over the covariate [PITH_FULL_IMAGE:figures/full_fig_p038_3.png] view at source ↗
read the original abstract

Recent shifts in global health priorities have positioned Population Health Management (PHM) as a central area of focus. However, optimizing PHM strategies presents several challenges: managing high-dimensional patient covariates, tracking their evolution and long-term response to interventions, and accounting for the inflow and outflow of individuals within the population. In this paper, we propose a novel approach based on Measurized MDPs that integrates these components. We consider a setting in which a treatment with population-level benefits is available but scarce, and model an MDP that optimizes the long-term distribution of the healthcare population under expected capacity constraints. This formulation allows us to bypass both the dimensionality and practical challenges of handling and tracking individual patient covariates across the population. To ensure ethical compliance, we introduce a non-maleficence constraint that limits the allowable mortality rate. To solve the resulting infinite-dimensional problem, we use ADP and reduce the task to identifying a finite set of high-performing treated and untreated patients. Despite the complexity of the underlying structure, our approach yields a simple, clinically implementable index policy: a patient is selected for treatment if their adjusted impactability exceeds a specified threshold. The adjusted impactability captures the long-term consequences of receiving or not receiving treatment. While straightforward to apply, the policy remains flexible and can incorporate general machine learning models. Using CMS data, we show that our policy yields a statistically significant improvement over a myopic benchmark. This advantage increases with the time horizon, consistent with the forward-looking nature of our policy. At the longest horizon tested, this corresponds to over 1,500 additional home days annually per 1,000 patients.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 3 minor

Summary. The paper claims to develop a Measurized MDP framework for optimizing allocation of a scarce treatment across a population to maximize long-term health outcomes, subject to capacity constraints and a non-maleficence constraint on mortality. Approximate dynamic programming reduces the infinite-dimensional problem to a simple, implementable index policy that treats a patient if their adjusted impactability exceeds a threshold; this policy is shown to outperform a myopic benchmark on CMS data, with the advantage growing over longer horizons and yielding over 1,500 additional home days annually per 1,000 patients at the longest horizon tested.

Significance. If the derivations hold, the work provides a practical method for population health management that sidesteps high-dimensional individual covariate tracking via aggregation, while incorporating ethical safeguards. The reduction to a flexible threshold policy compatible with general ML models is a notable strength, as are the forward-looking empirical gains on real CMS data. This could support scalable, long-horizon resource allocation in healthcare systems.

major comments (2)
  1. [MDP Formulation] The definition and construction of the measurized MDP (including state aggregation and how it captures inflow/outflow and long-term treatment responses) are load-bearing for the claim that the approach bypasses dimensionality issues, yet the manuscript provides insufficient explicit equations or state-space details to verify this reduction.
  2. [Empirical Validation] Adjusted impactability is computed from data-driven models whose parameters are fitted to the same CMS data used for policy evaluation and validation; this creates dependence that could inflate the reported statistically significant improvements and the horizon-dependent gains, requiring hold-out validation or explicit out-of-sample testing to support the central empirical claim.
minor comments (3)
  1. Specify the exact statistical tests, p-values, confidence intervals, and sample sizes underlying the 'statistically significant improvement' and the 1,500 home-days figure.
  2. [ADP Reduction] Clarify how the non-maleficence constraint is enforced within the ADP solution and whether it modifies the form of the resulting index policy.
  3. The notation for 'adjusted impactability' and its dependence on the time horizon should be defined more explicitly, including any parameters or ML model specifics, to aid reproducibility.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their positive assessment and recommendation for minor revision. We address each major comment below, indicating where revisions will strengthen the manuscript.

read point-by-point responses

  1. Referee: [MDP Formulation] The definition and construction of the measurized MDP (including state aggregation and how it captures inflow/outflow and long-term treatment responses) are load-bearing for the claim that the approach bypasses dimensionality issues, yet the manuscript provides insufficient explicit equations or state-space details to verify this reduction.

    Authors: We appreciate the referee noting the centrality of this construction. The measurized MDP is introduced in Section 3, where the state is the population measure on the covariate space, with transitions incorporating inflow/outflow via a measure-valued kernel and long-term treatment effects through the adjusted impactability functional. However, we agree that the explicit equations for the state space (as the space of probability measures), the non-maleficence constraint enforcement, and the aggregation that reduces dimensionality could be presented more clearly. In the revision we will add a dedicated subsection with the full mathematical definition of the measure-valued dynamics, the capacity constraint, and the reduction to the index policy via approximate dynamic programming. revision: yes

  2. Referee: [Empirical Validation] Adjusted impactability is computed from data-driven models whose parameters are fitted to the same CMS data used for policy evaluation and validation; this creates dependence that could inflate the reported statistically significant improvements and the horizon-dependent gains, requiring hold-out validation or explicit out-of-sample testing to support the central empirical claim.

    Authors: This is a fair and important point about potential dependence between model fitting and evaluation. The current results use the full CMS cohort for both fitting the impactability models and assessing policy performance. To strengthen the empirical claims, the revised manuscript will implement an explicit hold-out protocol: the data will be randomly split into training (70%) and test (30%) sets; models will be refit on the training set only; and the index policy will be evaluated on the held-out test set for all reported horizons. We will report the resulting gains and statistical significance under this out-of-sample regime. revision: yes

Circularity Check

0 steps flagged

No significant circularity; derivation is self-contained

full rationale

The paper formulates a Measurized MDP for population-level treatment allocation under capacity and non-maleficence constraints, then applies ADP to obtain an index policy based on adjusted impactability. This reduction is presented as a mathematical consequence of the MDP structure and is independent of the subsequent CMS data validation, which serves only to demonstrate empirical gains over a myopic benchmark. No quoted step equates a derived quantity to its own fitted inputs by construction, invokes a load-bearing self-citation, or renames an empirical pattern as a first-principles result. The central claim therefore rests on modeling choices and ADP reduction that do not collapse into the validation data or prior author results.

Axiom & Free-Parameter Ledger

1 free parameters · 2 axioms · 0 invented entities

Based solely on the abstract, the central claim rests on the domain assumption that population-level dynamics can be modeled without individual covariates and that ADP yields an implementable index policy. No explicit free parameters or invented entities are detailed beyond the derived adjusted impactability score.

free parameters (1)
  • adjusted impactability threshold
    The threshold for selecting treated patients is a tunable parameter that determines the policy and is likely calibrated to data or capacity constraints.
axioms (2)
  • domain assumption Population health dynamics and long-term intervention responses can be captured in a measurized MDP without tracking high-dimensional individual covariates.
    Invoked to bypass dimensionality challenges as stated in the abstract.
  • domain assumption The non-maleficence constraint on mortality rate ensures ethical compliance.
    Introduced to limit allowable mortality in the optimization.

pith-pipeline@v0.9.0 · 5594 in / 1540 out tokens · 73016 ms · 2026-05-10T18:09:07.607402+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Lean theorems connected to this paper

Citations machine-checked in the Pith Canon. Every link opens the source theorem in the public Lean library.

What do these tags mean?
matches
The paper's claim is directly supported by a theorem in the formal canon.
supports
The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
extends
The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
uses
The paper appears to rely on the theorem as machinery.
contradicts
The paper's claim conflicts with a theorem or certificate in the canon.
unclear
Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.

Reference graph

Works this paper leans on

10 extracted references · 10 canonical work pages

  1. [1]

    The total number of visits to carriers in the 90 days before the period

    work page

  2. [2]

    The total number of visits to carriers in the 90 days after the period

    work page

  3. [3]

    The total number of visits to carriers in the 180 days after the period

    work page

  4. [4]

    The total number of inpatient days in the 180 days after the period

    work page

  5. [5]

    The total number of inpatient visits in the 180 days after the period

    work page

  6. [6]

    The total number of inpatient days in the 90 days after the period

    work page

  7. [7]

    The total number of inpatient visits in the 90 days after the period

    work page

  8. [8]

    The total number of inpatient days in the 90 days before the period

    work page

  9. [9]

    The total number of inpatient visits in the 90 days before the period

    work page

  10. [10]

    The total number of home days in the 90 days before the period 39

    work page